Injectable Drugs Market is Expected to Grow at a CAGR of 8.23% Over the Forecast period (2016-2024)

Posted on 2018-08-01 by Goldstein Research in Healthcare // 0 Comments

New York, USA, 2018-Aug-01 — /EPR Network/ —According to Goldstein Research, Global injectable drugs market is expected to reach USD513.5 billion by the end of 2024 from USD 272.7 billion in 2016, growing at a CAGR of 8.23% over the forecast period, 2016-2024. The rise in per capita income of patients and their rising awareness and opportunities popping up from mergers and acquisitions are the major growth drivers for Global injectable drugs market. Global Injectable drugs market Research has been done on the basis of product type and geography.

Complex biologics accounted for the largest market share of 60.0% in 2016 due to rising demand for licensed new drugs for biologics. Vaccines and insulin follow the complex biologics market share. Global Injectable drugs market is dominated by Asia-Pacific region, growing at a CAGR of 10.51% over the forecast period. China, Japan and Singapore are deemed to be the largest injectable drugs market in the APAC region. Europe closely follows the APAC market share. Europe has injectable drug technologies for life-threatening health problems, thus pushing the growth of the European market.

Market Segmentation

On the basis of our in-depth analysis, Global Injectable Drugs Market can be segmented as follows:

Based on Product Type

Vaccines
Insulin
Conventional Therapeutics
Complex Biologics

Based on Region

North America (US, Canada) {Market Share (%), Market Size (USD Billion, Adoption Rate (%)}
Europe (UK, France, Italy, Germany, Spain, Hungary, Sweden, Russia, Poland and Rest of Europe) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
The Middle East and Africa (GCC Countries, North Africa, South Africa and Rest of the Middle East & Africa) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
Latin America (Brazil, Mexico and Rest of Latin America) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
Asia Pacific (China, Japan, India, Singapore, South Korea, Australia, New Zealand and Rest of Asia-Pacific) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
Rest of the World {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}

“Global Injectable Drugs Industry Analysis ”contains the detailed overview of the Injectable drugs market. On the basis of our in-depth analysis, the market can be segmented in terms of market segmentation by product type and geography.

Further, for the in-depth analysis, Global Injectable Drugs Market Report encompasses the industry growth drivers, market challenges, risk analysis, market attractiveness, BPS (Base Point Scale) analysis, Porter’s five force model and SWOT analysis. This market analysis reports also includes competitive outlook of some of the major players profiling of companies such as Pfizer Inc., Johnson & Johnson, Novartis AG, Merck & Co. Inc., Baxter International Inc., Sanofi, GlaxoSmithKline Plc., AstraZeneca, GILEAD SCIENCES, Inc., Nova Nordisk A/S, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical,etc.

The company profiles include business strategy, geographical revenue distribution, major information of the companies which encompasses business outlook, products, services and industries catered, financial analysis of the company and recent developments.

Overall, the report represents the Global injectable drugs market share along with the market forecast that will help industry consultants, technology providers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market-centric strategies according to the ongoing and expected trends in the future.

Download Exclusive Sample Report @ https://www.goldsteinresearch.com/request-sample/global-injectable-drugs-market-outlook-2024-global-opportunity-and-demand-analysis-market-forecast-2016-2024

About Goldstein Research

Based in the US, Goldstein Research currently has a strong presence in the American and Asian countries. In the next five years, we strive to expand our reach to 50+ nations spanning across Europe, Asia and parts of the Middle East and Africa. We strive to realize a strong brand presence globally through our quality research and forecasting solutions.

Our mission is simple: to develop market opportunity insight report, help our clients make powerful future decisions to keep them well ahead of the game which is the market, and leave a mark across businesses and communities through our well-defined ideas and clear-cut forecasts.

Our market research reports provide in-depth analysis of Global and regional variations along with competitors’ overview. Our analysts working on healthcare market reports helping various tech-giants, tech start-ups and entry players to assess the current and upcoming business scenario. We believe in the rigorous examination of the current market scenario and build around creative ideas and approaches that are most suitable for our clients’ needs and business agenda.

Market Segmentation

Based on Product Type

Based on Region

About Goldstein Research

Matched content

Editor’s pick